HL7.TERMINOLOGY\RoleClassPartitive

HL7 Terminology
1.0.0 - Publication

This page is part of the HL7 Terminology (v1.0.0: Release) based on FHIR R4. The current version which supercedes this version is 5.2.0. For a full list of available versions, see the Directory of published versions

RoleClassPartitive

Summary

Defining URL:

http://terminology.hl7.org/ValueSet/v3-RoleClassPartitive

Version:

2.0.0

Name:

RoleClassPartitive

Status:

Active

Title:

RoleClassPartitive

Definition:

An association between two Entities where the playing Entity is considered in some way "part" of the scoping Entity, e.g., as a member, component, ingredient, or content. Being "part" in the broadest sense of the word can mean anything from being an integral structural component to a mere incidental temporary association of a playing Entity with a (generally larger) scoping Entity.

OID:

2.16.840.1.113883.1.11.10429 (for OID based terminology systems)

Source Resource:

XML / JSON / Turtle

References

This value set is not used

Content Logical Definition

Logical Definition (CLD)

This value set includes codes based on the following rules:

Include codes from http://terminology.hl7.org/CodeSystem/v3-RoleClass where concept is-a _RoleClassPartitive

Exclude these codes as defined in http://terminology.hl7.org/CodeSystem/v3-RoleClass

Code	Display
_RoleClassPartitive	RoleClassPartitive	An association between two Entities where the playing Entity is considered in some way "part" of the scoping Entity, e.g., as a member, component, ingredient, or content. Being "part" in the broadest sense of the word can mean anything from being an integral structural component to a mere incidental temporary association of a playing Entity with a (generally larger) scoping Entity.

Expansion

This value set contains 27 concepts

Expansion based on RoleClass v2.0.0 (CodeSystem)

All codes from system http://terminology.hl7.org/CodeSystem/v3-RoleClass

Code	Display	Definition
CONT	content	Relates a material as the content (player) to a container (scoper). Unlike ingredients, the content and a container remain separate (not mixed) and the content can be removed from the container. A content is not part of an empty container.
EXPAGTCAR	exposure agent carrier	An exposure agent carrier is an entity that is capable of conveying an exposure agent from one entity to another. The scoper of the role must be the exposure agent (e.g., pathogen).
EXPVECTOR	exposure vector	Description: A vector is a living subject that carries an exposure agent. The vector does not cause the disease itself, but exposes targets to the exposure agent. A mosquito carrying malaria is an example of a vector. The scoper of the role must be the exposure agent (e.g., pathogen).
FOMITE	fomite	Description: A fomite is a non-living entity that is capable of conveying exposure agent from one entity to another. A doorknob contaminated with a Norovirus is an example of a fomite. Anyone touching the doorknob would be exposed to the virus. The scoper of the role must be the exposure agent (e.g., pathogen).
INGR	ingredient	Relates a component (player) to a mixture (scoper). E.g., Glucose and Water are ingredients of D5W, latex may be an ingredient in a tracheal tube.
ACTI	active ingredient	Definition: a therapeutically active ingredient (player) in a mixture (scoper), where the mixture is typically a manufactured pharmaceutical. It is unknown if the quantity of such an ingredient is expressed precisely in terms of the playing ingredient substance, or, if it is specified in terms of a closely related substance (active moiety or reference substance).
ACTIB	active ingredient - basis of strength	Description: Active ingredient, where the ingredient substance (player) is itself the "basis of strength", i.e., where the Role.quantity specifies exactly the quantity of the player substance in the medicine formulation. Examples: Lopressor 50 mg actually contains 50 mg of metoprolol succinate, even though the active moiety is metoprolol, but also: Tenormin 50 mg contain 50 mg of atenolol, as free base, i.e., where the active ingredient atenolol is also the active moiety.
ACTIM	active ingredient - moiety is basis of strength	Description: Active ingredient, where not the ingredient substance (player), but itaTMs active moiety is the "basis of strength", i.e., where the Role.quantity specifies the quantity of the player substance's active moiety in the medicine formulation. Examples: 1 mL of Betopic 5mg/mL eye drops contains 5.6 mg betaxolol hydrochloride equivalent to betaxolol base 5 mg.
ACTIR	active ingredient - reference substance is basis of strength	Description: Active ingredient, where not the ingredient substance (player) but another reference substance with the same active moiety, is the "basis of strength", i.e., where the Role.quantity specifies the quantity of a reference substance, similar but different from the player substance's in the medicine formulation. Examples: Toprol-XL 50 mg contains 47.5 mg of metoprolol succinate equivalent to 50 mg of metoprolol tartrate.
ADJV	adjuvant	A component (player) added to enhance the action of an active ingredient (scoper) (in the manner of a catalyst) but which has no active effect in and of itself. Such ingredients are significant in defining equivalence of products in a way that inactive ingredients are not.
ADTV	additive	An ingredient (player) that is added to a base (scoper), that amounts to a minor part of the overall mixture.
BASE	base	A base ingredient (player) is what comprises the major part of a mixture (scoper). E.g., Water in most i.v. solutions, or Vaseline in salves. Among all ingredients of a material, there should be only one base. A base substance can, in turn, be a mixture.
CNTM	contaminant ingredient	An ingredient whose presence is not intended but may not be reasonably avoided given the circumstances of the mixture's nature or origin.
IACT	inactive ingredient	An ingredient which is not considered therapeutically active, e.g., colors, flavors, stabilizers, or preservatives, fillers, or structural components added to an active ingredient in order to facilitate administration of the active ingredient but without being considered therapeutically active. An inactive ingredient need not be biologically inert, e.g., might be active as an allergen or might have a pleasant taste, but is not an essential constituent delivering the therapeutic effect.
COLR	color additive	A substance (player) influencing the optical aspect of material (scoper).
FLVR	flavor additive	A substance (player) added to a mixture (scoper) to make it taste a certain way. In food the use is obvious, in pharmaceuticals flavors can hide disgusting taste of the active ingredient (important in pediatric treatments).
PRSV	preservative	A substance (player) added to a mixture (scoper) to prevent microorganisms (fungi, bacteria) to spoil the mixture.
STBL	stabilizer	A stabilizer (player) added to a mixture (scoper) in order to prevent the molecular disintegration of the main substance.
MECH	mechanical ingredient	An ingredient (player) of a medication (scoper) that is inseparable from the active ingredients, but has no intended chemical or pharmaceutical effect itself, but which may have some systemic effect on the patient. An example is a collagen matrix used as a base for transplanting skin cells. The collagen matrix can be left permanently in the graft site. Because it is of bovine origin, the patient may exhibit allergies or may have cultural objections to its use.
LOCE	located entity	Relates an entity (player) to a location (scoper) at which it is present in some way. This presence may be limited in time.
STOR	stored entity	Relates an entity (player) (e.g. a device) to a location (scoper) at which it is normally found or stored when not used.
MBR	member	A role played by an entity that is a member of a group. The group provides the scope for this role. Among other uses, groups as used in insurance (groups of covered individuals) and in scheduling where resources may be grouped for scheduling and logistical purposes.
PART	part	Definition: an association between two Entities where the playing Entity (the part) is a component of the whole (scoper) in the sense of an integral structural component, that is distinct from other parts in the same whole, has a distinct function in the whole, and, as an effect, the full integrity of the whole depends (to some degree) on the presence of this part, even though the part may often be separable from the whole. Discussion: Part is defined in opposition to (a) ingredient (not separable), (b) content (not a functional component), and (c) member (not functionally distinct from other members).
ACTM	active moiety	The molecule or ion that is responsible for the intended pharmacological action of the drug substance, excluding those appended or associated parts of the molecule that make the molecule an ester, salt (including a salt with hydrogen or coordination bonds), or other noncovalent derivative (such as a complex, chelate, or clathrate). Examples: heparin-sodium and heparin-potassium have the same active moiety, heparin; the active moiety of morphine-hydrochloride is morphine.
SPEC	specimen	A role played by a material entity that is a specimen for an act. It is scoped by the source of the specimen.
ALQT	aliquot	A portion (player) of an original or source specimen (scoper) used for testing or transportation.
ISLT	isolate	A microorganism that has been isolated from other microorganisms or a source matrix.

Explanation of the columns that may appear on this page:

Level

A few code lists that FHIR defines are hierarchical - each code is assigned a level. In this scheme, some codes are under other codes, and imply that the code they are under also applies

Source

The source of the definition of the code (when the value set draws in codes defined elsewhere)

Code

The code (used as the code in the resource instance)

Display

The display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application

Definition

An explanation of the meaning of the concept

Comments

Additional notes about how to use the code

History

Date

Action

Author

Custodian

Comment

2020-05-06

revise